rivastigmine / Generic mfg.  >>  Phase 3
Welcome,         Profile    Billing    Logout  

1 Trials

   Remove FilterRemove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
rivastigmine / Generic mfg.
NCT05564169: Masitinib in Patients With Mild to Moderate Alzheimer's Disease

Not yet recruiting
3
600
Europe
Placebo, Placebo Oral Tablet, Masitinib (4.5), AB1010, Standard of care
AB Science
Alzheimer Disease
12/26
12/26

Download Options